These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 33846224)

  • 1. Longitudinal Peripheral Blood Transcriptional Analysis Reveals Molecular Signatures of Disease Progression in COVID-19 Patients.
    Yan Q; Li P; Ye X; Huang X; Feng B; Ji T; Chen Z; Li F; Zhang Y; Luo K; Chen F; Mo X; Wang J; Feng L; Hu F; Lei C; Qu L; Chen L
    J Immunol; 2021 May; 206(9):2146-2159. PubMed ID: 33846224
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A single-cell atlas of the peripheral immune response in patients with severe COVID-19.
    Wilk AJ; Rustagi A; Zhao NQ; Roque J; Martínez-Colón GJ; McKechnie JL; Ivison GT; Ranganath T; Vergara R; Hollis T; Simpson LJ; Grant P; Subramanian A; Rogers AJ; Blish CA
    Nat Med; 2020 Jul; 26(7):1070-1076. PubMed ID: 32514174
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of SARS-CoV-2 infection on the recovery of peripheral blood mononuclear cells by density gradient.
    Manunta MDI; Lamorte G; Ferrari F; Trombetta E; Tirone M; Bianco C; Cattaneo A; Santoro L; Baselli G; Brasca M; Ostadreza M; Erba E; Gori A; Bandera A; Porretti L; Valenti LVC; Prati D
    Sci Rep; 2021 Mar; 11(1):4904. PubMed ID: 33649400
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dysregulated early transcriptional signatures linked to mast cell and interferon responses are implicated in COVID-19 severity.
    MacCann R; Leon AAG; Gonzalez G; Carr MJ; Feeney ER; Yousif O; Cotter AG; de Barra E; Sadlier C; Doran P; Mallon PW
    Front Immunol; 2023; 14():1166574. PubMed ID: 37261339
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biomarkers and Immune Repertoire Metrics Identified by Peripheral Blood Transcriptomic Sequencing Reveal the Pathogenesis of COVID-19.
    Liu Y; Wu Y; Liu B; Zhang Y; San D; Chen Y; Zhou Y; Yu L; Zeng H; Zhou Y; Zhou F; Yang H; Yin L; Huang Y
    Front Immunol; 2021; 12():677025. PubMed ID: 34504487
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dysregulated Innate and Adaptive Immune Responses Discriminate Disease Severity in COVID-19.
    Janssen NAF; Grondman I; de Nooijer AH; Boahen CK; Koeken VACM; Matzaraki V; Kumar V; He X; Kox M; Koenen HJPM; Smeets RL; Joosten I; Brüggemann RJM; Kouijzer IJE; van der Hoeven HG; Schouten JA; Frenzel T; Reijers MHE; Hoefsloot W; Dofferhoff ASM; van Apeldoorn MJ; Blaauw MJT; Veerman K; Maas C; Schoneveld AH; Hoefer IE; Derde LPG; van Deuren M; van der Meer JWM; van Crevel R; Giamarellos-Bourboulis EJ; Joosten LAB; van den Heuvel MM; Hoogerwerf J; de Mast Q; Pickkers P; Netea MG; van de Veerdonk FL
    J Infect Dis; 2021 Apr; 223(8):1322-1333. PubMed ID: 33524124
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Single-cell analysis of COVID-19, sepsis, and HIV infection reveals hyperinflammatory and immunosuppressive signatures in monocytes.
    Liu N; Jiang C; Cai P; Shen Z; Sun W; Xu H; Fang M; Yao X; Zhu L; Gao X; Fang J; Lin J; Guo C; Qu K
    Cell Rep; 2021 Oct; 37(1):109793. PubMed ID: 34587478
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dynamic blood single-cell immune responses in patients with COVID-19.
    Huang L; Shi Y; Gong B; Jiang L; Zhang Z; Liu X; Yang J; He Y; Jiang Z; Zhong L; Tang J; You C; Jiang Q; Long B; Zeng T; Luo M; Zeng F; Zeng F; Wang S; Yang X; Yang Z
    Signal Transduct Target Ther; 2021 Mar; 6(1):110. PubMed ID: 33677468
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Single-cell RNA sequencing reveals characteristics of myeloid cells in post-acute sequelae of SARS-CoV-2 patients with persistent respiratory symptoms.
    Yoon H; Dean LS; Jiyarom B; Khadka VS; Deng Y; Nerurkar VR; Chow DC; Shikuma CM; Devendra G; Koh Y; Park J
    Front Immunol; 2023; 14():1268510. PubMed ID: 38259488
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Single-cell transcriptomes of peripheral blood cells indicate and elucidate severity of COVID-19.
    Xie X; Cheng X; Wang G; Zhang B; Liu M; Chen L; Cheng H; Hao S; Zhou J; Zhu P; Cheng T
    Sci China Life Sci; 2021 Oct; 64(10):1634-1644. PubMed ID: 33564978
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhanced Expression of Autoantigens During SARS-CoV-2 Viral Infection.
    Saheb Sharif-Askari N; Saheb Sharif-Askari F; Ahmed SBM; Hannawi S; Hamoudi R; Hamid Q; Halwani R
    Front Immunol; 2021; 12():686462. PubMed ID: 34276672
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Integrated cytokine and metabolite analysis reveals immunometabolic reprogramming in COVID-19 patients with therapeutic implications.
    Xiao N; Nie M; Pang H; Wang B; Hu J; Meng X; Li K; Ran X; Long Q; Deng H; Chen N; Li S; Tang N; Huang A; Hu Z
    Nat Commun; 2021 Mar; 12(1):1618. PubMed ID: 33712622
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunophenotyping of COVID-19 and influenza highlights the role of type I interferons in development of severe COVID-19.
    Lee JS; Park S; Jeong HW; Ahn JY; Choi SJ; Lee H; Choi B; Nam SK; Sa M; Kwon JS; Jeong SJ; Lee HK; Park SH; Park SH; Choi JY; Kim SH; Jung I; Shin EC
    Sci Immunol; 2020 Jul; 5(49):. PubMed ID: 32651212
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemokines and eicosanoids fuel the hyperinflammation within the lungs of patients with severe COVID-19.
    Zaid Y; Doré É; Dubuc I; Archambault AS; Flamand O; Laviolette M; Flamand N; Boilard É; Flamand L
    J Allergy Clin Immunol; 2021 Aug; 148(2):368-380.e3. PubMed ID: 34111453
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mitochondrial metabolic manipulation by SARS-CoV-2 in peripheral blood mononuclear cells of patients with COVID-19.
    Ajaz S; McPhail MJ; Singh KK; Mujib S; Trovato FM; Napoli S; Agarwal K
    Am J Physiol Cell Physiol; 2021 Jan; 320(1):C57-C65. PubMed ID: 33151090
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differentially expressed immune response genes in COVID-19 patients based on disease severity.
    Li S; Duan X; Li Y; Li M; Gao Y; Li T; Li S; Tan L; Shao T; Jeyarajan AJ; Chen L; Han M; Lin W; Li X
    Aging (Albany NY); 2021 Mar; 13(7):9265-9276. PubMed ID: 33780352
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lysosome activation in peripheral blood mononuclear cells and prognostic significance of circulating LC3B in COVID-19.
    Fang S; Zhang L; Liu Y; Xu W; Wu W; Huang Z; Wang X; Liu H; Sun Y; Zhang R; Peng B; Liu X; Sun X; Yu J; Chan FKL; Ng SC; Wong SH; Wang MHT; Gin T; Joynt GM; Hui DSC; Feng T; Wu WKK; Chan MTV; Zou X; Xia J
    Brief Bioinform; 2021 Mar; 22(2):1466-1475. PubMed ID: 33620066
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aging whole blood transcriptome reveals candidate genes for SARS-CoV-2-related vascular and immune alterations.
    de Almeida Chuffa LG; Freire PP; Dos Santos Souza J; de Mello MC; de Oliveira Neto M; Carvalho RF
    J Mol Med (Berl); 2022 Feb; 100(2):285-301. PubMed ID: 34741638
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dysregulated transcriptional responses to SARS-CoV-2 in the periphery.
    McClain MT; Constantine FJ; Henao R; Liu Y; Tsalik EL; Burke TW; Steinbrink JM; Petzold E; Nicholson BP; Rolfe R; Kraft BD; Kelly MS; Saban DR; Yu C; Shen X; Ko EM; Sempowski GD; Denny TN; Ginsburg GS; Woods CW
    Nat Commun; 2021 Feb; 12(1):1079. PubMed ID: 33597532
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnosis of SARS-CoV-2 infection in the setting of the cytokine release syndrome.
    Azar MM; Shin JJ; Kang I; Landry M
    Expert Rev Mol Diagn; 2020 Nov; 20(11):1087-1097. PubMed ID: 32990479
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.